Keros Therapeutics
Patents, Design & Utilities
Last updated:
List of all Keros Therapeutics patents 11 in total
| Status | Patent |
|---|---|
Application | Utility: ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: ALK2 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 19 Aug 2021 |
Grant | Utility: Activin receptor type IIa variants and methods of use thereof Filling date: 26 Sep 2025 Issue date: 17 Aug 2021 |
Application | Utility: CRYSTAL FORMS OF AN ALK2 INHIBITOR Filling date: 26 Sep 2025 Issue date: 5 Aug 2021 |
Grant | Utility: Activin receptor type IIA variants and methods of use thereof Filling date: 26 Sep 2025 Issue date: 25 May 2021 |
Application | Utility: ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: ACTIVIN RECEPTOR TYPE IIB VARIANTS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: GDNF FUSION POLYPEPTIDES AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 19 Sep 2019 |
Showing 1 to 11 of 11 patents.